Fig. 4From: Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapySingle-fraction 4D dynamic dose distributions without considering rescanning on exhale phase for (a) SPArc and (b) RO-IMPT plan for patient 13 and the boxplot of the doses encompassing 95% (D95%) ITV on exhalation phase for group 2 patients based on single-fraction 4D dynamic dose simulated with different starting breathing phase (c)Back to article page